GHTC sends FY25 letters to congressional appropriators
GHTC sends letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2025 budget.
Check out the latest news and announcements from GHTC.
GHTC sends letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2025 budget.
GHTC sends letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2025 budget.
GHTC submitted the following intervention at a US Department of Health and Human Services (HHS) listening session held on April 18 ahead of the G20 Health Ministers' Meeting in Rio de Janeiro.
GHTC submitted the following intervention at a US Department of Health and Human Services (HHS) listening session held on April 11 on the Intergovernmental Negotiating Body's pandemic accord process.
GHTC welcomes the World Health Organization's (WHO's) newly announced plans to parallel the processes of prequalification and/or Emergency Use Listing assessments and recommendations on product use to expedite access to health products.
The newly published report from GHTC and Policy Cures Research, Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World, which looks at the returns from US investment in global health R&D, was featured in articles from Research Professional News, CIDRAP, and Infosalus.